While eligibility can only be determined by a licensed provider, there are common factors that may indicate whether someone could be a good fit for a physician-guided weight loss program that may incorporate compounded GLP-1 or GLP-1/GIPbased medications
Third, your baseline eating patterns may be masking subtle effects
Semaglutide has not been studied in patients with a history of pancreatitis to determine whether these patients are at increased risk for pancreatitis
Dosing can vary depending on concentration, which is why many patients use a calculator to avoid mistakes
Fasting insulin, HOMA-IR (insulin resistance index), lipid panel abnormalities, and inflammatory markers like high-sensitivity CRP provide objective evidence of metabolic disease
However, you should still expect to complete a video/phone call